{"DataElement":{"publicId":"2407018","version":"1","preferredName":"Nipple Aspirate Fluid Test Name","preferredDefinition":"Tests performed on fluid aspirated from the nipple.","longName":"NPPL_ASPR_FL_TST_NM","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"2192062","version":"1","preferredName":"Nipple Aspirate Result","preferredDefinition":"information related to nipple aspirate result.","longName":"NIPPLE_ASPR_RESULT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206510","version":"1","preferredName":"Nipple Aspirate","preferredDefinition":"The pigmented projection on the surface of the breast. Ducts that conduct milk from the mammary glands to the surface of the breast exit through the nipple. (from MedTerms Medical Dictionary; medterms.com):(AS-pi-rit) Fluid withdrawn from a lump, often a cyst, or a nipple.","longName":"C12299:C13347","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nipple","conceptCode":"C12299","definition":"The pigmented protuberance on the surface of the breast through which milk is drawn from the breast.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Aspirate","conceptCode":"C13347","definition":"Fluid withdrawn from a body cavity, organ, cyst, or tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F7F6-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177339","version":"1","preferredName":"Result","preferredDefinition":"Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"Result","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-528F-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8A09C0C-EE22-0B85-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-11-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2407014","version":"1","preferredName":"Nipple Aspirate Fluid Test Name","preferredDefinition":"The name of the nipple aspirate fluid test.","longName":"NPPL_ASPR_FL_TST_NM","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Estrone","valueDescription":"Estrone","ValueMeaning":{"publicId":"2576306","version":"1","preferredName":"Estrone","longName":"2576306","preferredDefinition":"One of three naturally occuring estrogens synthesized from androstenedione in the adrenal glands and peripheral tissues by aromatization and is the primary estrogen produced after menopause.(NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrone","conceptCode":"C2294","definition":"One of three naturally occurring estrogens synthesized from androstenedione in the adrenal glands and peripheral tissues by aromatization and is the primary estrogen produced after menopause.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F71F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-21","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0149E795-4806-054B-E044-0003BA3F9857","beginDate":"2005-09-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-21","modifiedBy":"MAESKEB","dateModified":"2005-09-21","deletedIndicator":"No"},{"value":"Estrone-Sulfate","valueDescription":"Estrone-Sulfate","ValueMeaning":{"publicId":"2576307","version":"1","preferredName":"Estrone-Sulfate","longName":"2576307","preferredDefinition":"An aqueous substance that is the sulfate salt form of estrone. (NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrone Sulfate","conceptCode":"C1091","definition":"An aqueous substance that is the sulfate salt form of estrone. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F720-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-21","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0149E795-480C-054B-E044-0003BA3F9857","beginDate":"2005-09-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-21","modifiedBy":"MAESKEB","dateModified":"2005-09-21","deletedIndicator":"No"},{"value":"Progesterone","valueDescription":"PROGESTERONE","ValueMeaning":{"publicId":"2563599","version":"1","preferredName":"PROGESTERONE","longName":"2563599","preferredDefinition":"Produced in the corpus luteum and by the placenta, as an antagonist of estrogens. Promotes proliferation of uterine mucosa and the implantation of the blastocyst, prevents further follicular development. (On-line Medical Dictionary)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progesterone","conceptCode":"C2297","definition":"Produced in the corpus luteum and by the placenta, as an antagonist of estrogens. Promotes proliferation of uterine mucosa and the implantation of the blastocyst, prevents further follicular development.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C57C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-12-04","endDate":null,"createdBy":"CVALMONT","dateCreated":"2002-12-04","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0149E795-480E-054B-E044-0003BA3F9857","beginDate":"2005-09-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-21","modifiedBy":"MAESKEB","dateModified":"2005-09-21","deletedIndicator":"No"},{"value":"Estradiol","valueDescription":"Estradiol","ValueMeaning":{"publicId":"2576827","version":"1","preferredName":"Estradiol","longName":"2576827","preferredDefinition":"Estradiol (E2). beta-estradiol; 17 beta-estradiol; 1,3,5(10)-estratriene-3,17 beta-diol; the most potent naturally occurring estrogen in mammals, formed by the ovary, placenta, testis, and possibly the adrenal cortex; therapeutic indications for estradiol are those typical of an estrogen. alpha-Estradiol, (17 alpha-estradiol), exhibits considerably less biologic activity. Estradiol is used in the treatment of menstrual disorders, menopause problems, etc. SYN estrogenic hormone, oestradiol.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estradiol","conceptCode":"C2295","definition":"The most potent form of the naturally occurring steroid sex hormone in humans, produced by ovary, placenta, testis, and in small amount by adrenal cortex. Estradiol binds to a specific intracellular estrogen receptor located in female organs, breasts, hypothalamus and pituitary. The receptor-ligand complex promotes gene expression necessary for the maintenance of fertility and secondary sexual characteristics in females. In addition, estradiol exhibits mild anabolic and metabolic properties, and increases blood coagulability. Estradiol, the principal intracellular human estrogen, is substantially more active at the cellular level than its metabolites, estrone and estriol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F928-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-11-08","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"608908F3-05E3-6642-E040-BB89AD431038","beginDate":"2009-01-15","endDate":null,"createdBy":"CDECURATE","dateCreated":"2009-01-15","modifiedBy":"CDECURATE","dateModified":"2009-01-15","deletedIndicator":"No"},{"value":"Bisphenol","valueDescription":"Bisphenol","ValueMeaning":{"publicId":"2823954","version":"1","preferredName":"Bisphenol","longName":"2823954","preferredDefinition":"Bisphenol","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"60624E71-2098-4C06-E040-BB89AD43132A","latestVersionIndicator":"Yes","beginDate":"2009-01-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-01-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"608908F3-05F0-6642-E040-BB89AD431038","beginDate":"2009-01-15","endDate":null,"createdBy":"CDECURATE","dateCreated":"2009-01-15","modifiedBy":"CDECURATE","dateModified":"2009-01-15","deletedIndicator":"No"},{"value":"Tamoxifen","valueDescription":"TAMOXIFEN","ValueMeaning":{"publicId":"2561706","version":"1","preferredName":"TAMOXIFEN","longName":"2561706","preferredDefinition":"TAMOXIFEN","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tamoxifen Citrate","conceptCode":"C855","definition":"The citrate salt of an antineoplastic nonsteroidal selective estrogen receptor modulator (SERM). Tamoxifen competitively inhibits the binding of estradiol to estrogen receptors, thereby preventing the receptor from binding to the estrogen-response element on DNA. The result is a reduction in DNA synthesis and cellular response to estrogen. In addition, tamoxifen up-regulates the production of transforming growth factor B (TGFb), a factor that inhibits tumor cell growth, and down-regulates insulin-like growth factor 1 (IGF-1), a factor that stimulates breast cancer cell growth. Tamoxifen also down-regulates protein kinase C (PKC) expression in a dose-dependant manner, inhibiting signal transduction and producing an antiproliferative effect in tumors such as malignant glioma and other cancers that overexpress PKC.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BE17-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-08","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-07-08","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"608908F3-05FD-6642-E040-BB89AD431038","beginDate":"2009-01-15","endDate":null,"createdBy":"CDECURATE","dateCreated":"2009-01-15","modifiedBy":"CDECURATE","dateModified":"2009-01-15","deletedIndicator":"No"},{"value":"Endoxifen","valueDescription":"Endoxifen","ValueMeaning":{"publicId":"2823955","version":"1","preferredName":"Endoxifen","longName":"2823955","preferredDefinition":"Endoxifen","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"60624E71-20CA-4C06-E040-BB89AD43132A","latestVersionIndicator":"Yes","beginDate":"2009-01-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-01-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"608908F3-060A-6642-E040-BB89AD431038","beginDate":"2009-01-15","endDate":null,"createdBy":"CDECURATE","dateCreated":"2009-01-15","modifiedBy":"CDECURATE","dateModified":"2009-01-15","deletedIndicator":"No"},{"value":"4-OHT","valueDescription":"4-OHT","ValueMeaning":{"publicId":"2823956","version":"1","preferredName":"4-OHT","longName":"2823956","preferredDefinition":"4-OHT","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"60624E71-20EF-4C06-E040-BB89AD43132A","latestVersionIndicator":"Yes","beginDate":"2009-01-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-01-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"608908F3-0617-6642-E040-BB89AD431038","beginDate":"2009-01-15","endDate":null,"createdBy":"CDECURATE","dateCreated":"2009-01-15","modifiedBy":"CDECURATE","dateModified":"2009-01-15","deletedIndicator":"No"},{"value":"Epidermal Growth Factor","valueDescription":"Epidermal Growth Factor","ValueMeaning":{"publicId":"2576305","version":"1","preferredName":"Epidermal Growth Factor","longName":"2576305","preferredDefinition":"Epidermal Growth Factor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F71E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-21","modifiedBy":"MAESKEB","dateModified":"2005-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6089BA61-C3E3-A497-E040-BB89AD432AF0","beginDate":"2009-01-15","endDate":null,"createdBy":"CDECURATE","dateCreated":"2009-01-15","modifiedBy":"CDECURATE","dateModified":"2009-01-15","deletedIndicator":"No"},{"value":"Cathepsin D","valueDescription":"Cathepsin D","ValueMeaning":{"publicId":"2825137","version":"1","preferredName":"Cathepsin D","longName":"2825137","preferredDefinition":"Cathepsin D","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6089BA61-C3EF-A497-E040-BB89AD432AF0","latestVersionIndicator":"Yes","beginDate":"2009-01-15","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-01-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6089BA61-C408-A497-E040-BB89AD432AF0","beginDate":"2009-01-15","endDate":null,"createdBy":"CDECURATE","dateCreated":"2009-01-15","modifiedBy":"CDECURATE","dateModified":"2009-01-15","deletedIndicator":"No"},{"value":"pS2","valueDescription":"PS2 protein (alzheimer-associated)","ValueMeaning":{"publicId":"3163140","version":"1","preferredName":"PS2 protein (alzheimer-associated)","longName":"3163140","preferredDefinition":"Integral membrane protein of Golgi and endoplasmic reticulum. Its homodimer is an essential component of the gamma-secretase complex that catalyzes the cleavage of membrane proteins such as NOTCH RECEPTORS and AMYLOID BETA-PROTEIN precursors. PSEN2 mutations cause ALZHEIMER DISEASE type 4.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PS2 protein (alzheimer-associated)","conceptCode":"C0528480","definition":"Integral membrane protein of Golgi and endoplasmic reticulum. Its homodimer is an essential component of the gamma-secretase complex that catalyzes the cleavage of membrane proteins such as NOTCH RECEPTORS and AMYLOID BETA-PROTEIN precursors. PSEN2 mutations cause ALZHEIMER DISEASE type 4.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9647C988-2FB8-1550-E040-BB89AD436BEF","latestVersionIndicator":"Yes","beginDate":"2010-11-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-11-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9647C988-2FD1-1550-E040-BB89AD436BEF","beginDate":"2010-11-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-11-30","modifiedBy":"ONEDATA","dateModified":"2010-11-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2407013","version":"1","preferredName":"Test Name","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.:The words or language units by which a thing is known.","longName":"C25294:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0149E795-47EB-054B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-21","modifiedBy":"ONEDATA","dateModified":"2005-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0149E795-47EC-054B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-21","modifiedBy":"MAESKEB","dateModified":"2010-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812502","version":"1","longName":"Unconjugated Isoflavones in Women at High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812736","version":"1","longName":"Transdermal 4-OHT vs oral TAM DCIS of the Breast","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Test","type":"Preferred Question Text","description":"Test","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0149E795-4812-054B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-21","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}